165 related articles for article (PubMed ID: 20974125)
1. Role of gamma-synuclein in microtubule regulation.
Zhang H; Kouadio A; Cartledge D; Godwin AK
Exp Cell Res; 2011 Jun; 317(10):1330-9. PubMed ID: 20974125
[TBL] [Abstract][Full Text] [Related]
2. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
Zhou Y; Inaba S; Liu J
Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new microtubule-interacting protein Mip-90.
González M; Cambiazo V; Maccioni RB
Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J
J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.
Gurler H; Yu Y; Choi J; Kajdacsy-Balla AA; Barbolina MV
Int J Mol Sci; 2015 Feb; 16(2):3419-33. PubMed ID: 25658796
[TBL] [Abstract][Full Text] [Related]
7. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
[No Abstract] [Full Text] [Related]
9. Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel.
Veitia R; David S; Barbier P; Vantard M; Gounon P; Bissery MC; Fellous A
Br J Cancer; 2000 Aug; 83(4):544-9. PubMed ID: 10945505
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
11. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
Zhao W; Song Y; Xu B; Zhan Q
Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
[TBL] [Abstract][Full Text] [Related]
13. Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel.
Nishio K; Arioka H; Ishida T; Fukumoto H; Kurokawa H; Sata M; Ohata M; Saijo N
Int J Cancer; 1995 Nov; 63(5):688-93. PubMed ID: 7591286
[TBL] [Abstract][Full Text] [Related]
14. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
Rosenblum MD; Shivers RR
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
[TBL] [Abstract][Full Text] [Related]
15. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
[TBL] [Abstract][Full Text] [Related]
16. End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability.
Luo Y; Li D; Ran J; Yan B; Chen J; Dong X; Liu Z; Liu R; Zhou J; Liu M
Protein Cell; 2014 Jun; 5(6):469-79. PubMed ID: 24748116
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
18. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel.
Ahmed AA; Mills AD; Ibrahim AE; Temple J; Blenkiron C; Vias M; Massie CE; Iyer NG; McGeoch A; Crawford R; Nicke B; Downward J; Swanton C; Bell SD; Earl HM; Laskey RA; Caldas C; Brenton JD
Cancer Cell; 2007 Dec; 12(6):514-27. PubMed ID: 18068629
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012.
Zhou J; Liu M; Aneja R; Chandra R; Joshi HC
Biochem Pharmacol; 2004 Dec; 68(12):2435-41. PubMed ID: 15548390
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells.
Parekh HK; Deng HB; Choudhary K; Houser SR; Simpkins H
Biochem Pharmacol; 2002 Mar; 63(6):1149-58. PubMed ID: 11931848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
